Currently, BAP1 genetic testing is recommended for patients who develop two or more tumors of the BAP1-TPDS spectrum or for those affected by only one of those tumors provided they have a first- or second-degree relative with a confirmed BAP1-TPDS tumor [6]. The gene discussed is BAP1; the disease is neoplasm.